Enabling Next-Generation Medicines.

Advanced cell and gene therapies remain expensive and hard to make, impeding powerful treatment options for patients across the spectrum of human disease. XDemics, a spin out from Caltech, tackles this challenge with a patented new technology that allows for production of cell and viral-based therapeutics in a natural and efficient way. We achieved this by separating the supply of oxygen and nutrients, creating the perfect environment for cells to thrive in a scaleable, controllable and high quality manner.